Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRON KID: IV vs Oral Iron for Craniosynostosis Surgery
NCT03231085Completed
- Sponsor
- CHU Montpellier
- Start
- Oct 2017
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric carboxymaltose in anemia, sponsored by CHU Montpellier. Primary endpoint: Variation from reference in hemoglobin rate at the day before surgery. Started Oct 2017; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03231085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03231085.